Prosecution Insights
Prosecution Insights
9 pending office actions • 5 clients • 8 examiners • 6 art units • 1 of 9 (11%) have an AI response strategy ready • 4 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 3 (33%) |
| §112 only | 1 (11%) |
| Double-patenting only | 2 (22%) |
| Double-patenting + other | 1 (11%) |
| No statute on record | 2 (22%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SABILA, MERCY HELLEN | 2 | 57.8% | +45.6% |
| BOWLES, DAVID PAUL | 1 | 71.0% | +22.3% |
| VALLE, ERNESTO | 1 | 60.9% | +35.7% |
| HELLMAN, KRISTINA M | 1 | 65.7% | +54.8% |
| BRETZ, COREY LANE | 1 | 0.0% | +0.0% |
| MEAH, MOHAMMAD Y | 1 | 70.9% | +42.7% |
| REYNOLDS, FRED H | 1 | 33.1% | +39.1% |
| HILL, STEPHANI A | 1 | 29.5% | +44.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 16434869 | Fe-Ni Nanocomposite Alloys | HILL, STEPHANI A | 21d |
| 18356591 | OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF | BRETZ, COREY LANE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18056117 | PEPTIDE CONJUGATES OF PEPTIDIC TUBULIN INHIBITORS AS THERAPEUTICS | REYNOLDS, FRED H | 98d overdue |
| 18471413 | COMPOSITIONS OF EXENDIN-4 DERIVATIVES | HELLMAN, KRISTINA M | 89d overdue |
| 16434869 | Fe-Ni Nanocomposite Alloys | HILL, STEPHANI A | 21d |
| 18372753 | METHODS AND COMPOSITIONS FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS | VALLE, ERNESTO | 34d |
| 19420848 | TREATMENT OF POST-BARIATRIC HYPOGLYCEMIA | BOWLES, DAVID PAUL | — |
| 19358715 | GLP-1R ANTAGONISM TO IMPROVE NUTRITION FOLLOWING GASTROINTESTINAL SURGERY | SABILA, MERCY HELLEN | — |
| 19353711 | BUFFERED FORMULATIONS OF EXENDIN (9-39) | SABILA, MERCY HELLEN | — |
| 18271121 | PROCESS FOR PREPARING A CONJUGATE LINKING MOIETY | MEAH, MOHAMMAD Y | — |
| Client (Assignee) | Pending OAs |
|---|---|
| Amylyx Pharmaceuticals | 4 |
| Stanford University | 2 |
| Cybrexa 2, Inc. | 1 |
| Cybrexa 4, Inc. | 1 |
| Carnegie Mellon University | 1 |
| Art Unit | Apps |
|---|---|
| 1654 | 4 |
| 1623 | 1 |
| 1635 | 1 |
| 1652 | 1 |
| 1658 | 1 |
| 1735 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19420848 | TREATMENT OF POST-BARIATRIC HYPOGLYCEMIA | Amylyx Pharmaceuticals, Inc. | BOWLES, DAVID PAUL | 1654 | DP | Final Rejection | — | Pending | Dec 16, 2025 |
| 19358715 | GLP-1R ANTAGONISM TO IMPROVE NUTRITION FOLLOWING GASTROINTESTINAL SURGERY | The Board Of Trustees Of The Leland Stanford Junior University | SABILA, MERCY HELLEN | 1654 | DPOther | Non-Final OA | — | Pending | Oct 15, 2025 |
| 19353711 | BUFFERED FORMULATIONS OF EXENDIN (9-39) | The Board Of Trustees Of The Leland Stanford Junior University | SABILA, MERCY HELLEN | 1654 | DP | Final Rejection | — | Pending | Oct 09, 2025 |
| 18372753 | METHODS AND COMPOSITIONS FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS | Amylyx Pharmaceuticals, Inc. | VALLE, ERNESTO | 1623 | Other | Non-Final OA | 34d | Pending | Sep 26, 2023 |
| 18471413 | COMPOSITIONS OF EXENDIN-4 DERIVATIVES | Amylyx Pharmaceuticals, Inc. | HELLMAN, KRISTINA M | 1654 | §103 | Final Rejection | 89d overdue | Pending | Sep 21, 2023 |
| 18356591 | OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF | Amylyx Pharmaceuticals, Inc. | BRETZ, COREY LANE | 1635 | §103 | Non-Final OA | — | Pending | Jul 21, 2023 |
| 18271121 | PROCESS FOR PREPARING A CONJUGATE LINKING MOIETY | Cybrexa 2, Inc. | MEAH, MOHAMMAD Y | 1652 | §112 | Non-Final OA | — | Pending | Jul 06, 2023 |
| 18056117 | PEPTIDE CONJUGATES OF PEPTIDIC TUBULIN INHIBITORS AS THERAPEUTICS | Cybrexa 4, Inc. | REYNOLDS, FRED H | 1658 | Other | Final Rejection | 98d overdue | Pending | Nov 16, 2022 |
| 16434869 | Fe-Ni Nanocomposite Alloys | Carnegie Mellon University | HILL, STEPHANI A | 1735 | §103 | Non-Final OA | 21d | AI Ready | Jun 07, 2019 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial